comparison of two nomograms of unfractionated heparin in patients with acute coronary syndrome.

نویسندگان

moneyreh modares mosadegh department of pharmacology, school of medicine, shahid sadoughi university of medical sciences, yazd, iran.

seyed mahmood sadr bafghi department of pharmacology, school of medicine, shahid sadoughi university of medical sciences, yazd, iran.

چکیده

heparin has an unpredictable pharmacokinetics and the responses of individuals may vary distinctly. therefore, different dosing nomograms have been proposed. the aim of this study was to compare two prevalent nomograms to adjust heparin doses in hospitalized patients with acute coronary syndrome.  one hundred and forty patients received heparin infusions based on one of two nomograms. group 1 received a bolus of 80 u/kg/h and an initial infusion rate of 17 u/kg/h. in the second group, a bolus of 60 u/kg (maximum of 4000 u) and an initial infusion rate of 12 u/kg/h (maximum of 900u/h) was given. activated partial thromboplastin time (aptt) was measured at the beginning and every 6 h for 48 hours. the rate of heparin was changed according to each nomogram in order to maintain aptt in the therapeutic level of 46-70 s. the time to pass threshold was on average 7.63±3.95 h for nomogram 1 and 11.05±4.41 h for the second nomogram (p<0.001). at 48 hours, the proportion of patients in the therapeutic range in group 1 was higher (72.86% vs 45.71%). the time patients stayed at the desired levels was significantly higher in nomogram 1 and they also required fewer heparin rate adjustments (3.41±1.55 vs 4.53±1.63). this study indicated that using nomogram 1 facilitated a more rapid achievement of the therapeutic threshold, higher proportion of patients in the therapeutic range for a longer time, and fewer changes of in the heparin rate.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Comparison of enoxaparin and dalteparin with unfractionated heparin in the treatment of non-ST elevated acute coronary syndrome.

BACKGROUND The term non-ST elevated Acute Coronary Syndrome (ACS) encompasses unstable Angina (USA) and non-ST segment elevated Myocardial Infarction (NSTEMI), both of which may end up in death or a fatal/non-fatal Myocardial Infarction (MI). Unfractionated heparin (UFH) has been shown to reduce death and MI in patients with USA and NSTEMI. Of late, there has been a great interest in the role o...

متن کامل

Bivalirudin or Unfractionated Heparin in Acute Coronary Syndromes.

BACKGROUND Conflicting evidence exists on the efficacy and safety of bivalirudin administered as part of percutaneous coronary intervention (PCI) in patients with an acute coronary syndrome. METHODS We randomly assigned 7213 patients with an acute coronary syndrome for whom PCI was anticipated to receive either bivalirudin or unfractionated heparin. Patients in the bivalirudin group were subs...

متن کامل

Unfractionated heparin dosing nomograms: road maps to where?

Weight-adjusted nomograms have been a significant advance in the use of unfractionated heparin (UFH). Clinical trials have demonstrated the ability of weight-adjusted nomograms to achieve a therapeutic activated partial thromboplastin time (aPTT) more rapidly than with standard UFH dosing. Despite this advantage, a significant number of patients have subtherapeutic and supratherapeutic aPTTs. R...

متن کامل

منابع من

با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید


عنوان ژورنال:
acta medica iranica

جلد ۵۱، شماره ۲، صفحات ۸۷-۹۳

میزبانی شده توسط پلتفرم ابری doprax.com

copyright © 2015-2023